The 2015 meeting will again include representatives from academia, the National Institutes of Health (NIH), Food and Drug Administration (FDA) and industry to discuss key aspects of neuropsychiatric drug development. This years meeting will be held in the heart of South Beach at the Loews Miami Beach Hotel.